Dermapharm Holding SE (DMP) — Cash Flow Quality Index
Dermapharm Holding SE (DMP) has a Cash Flow Quality Index of 2.50x as of December 2025. Operating cash flow of €92.40 Million exceeds net income of €36.89 Million, indicating high earnings quality where cash backs reported profits. Explore DMP long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Dermapharm Holding SE Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Dermapharm Holding SE across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check DMP tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Dermapharm Holding SE (2014–2025)
Year-by-year earnings quality comparison for Dermapharm Holding SE. For live market cap and the full company financial profile, see Dermapharm Holding SE (DMP) total market value.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.37x | €181.51 Million | €132.41 Million | ▲ +17.1% |
| 2024 | 1.17x | €201.38 Million | €172.00 Million | ▼ -66.7% |
| 2023 | 3.52x | €219.42 Million | €62.37 Million | ▲ +163.7% |
| 2022 | 1.33x | €288.53 Million | €216.30 Million | ▲ +56.1% |
| 2021 | 0.85x | €250.37 Million | €292.98 Million | ▼ -18.3% |
| 2020 | 1.05x | €131.10 Million | €125.28 Million | ▲ +14.5% |
| 2019 | 0.91x | €100.61 Million | €110.07 Million | ▼ -56.8% |
| 2018 | 2.12x | €159.13 Million | €75.23 Million | ▲ +89.6% |
| 2017 | 1.12x | €86.74 Million | €77.74 Million | ▼ -75.2% |
| 2016 | 4.50x | €76.78 Million | €17.06 Million | ▲ +43.7% |
| 2015 | 3.13x | €40.38 Million | €12.90 Million | ▼ -98.6% |
| 2014 | 228.93x | €54.26 Million | €237.00K | — |